GLP-1 Receptor Agonists: What They Are and How They Work

When you eat, your gut releases GLP-1 naturally. GLP-1 receptor agonists act on the same receptors that this hormone targets, amplifying several effects at once. Understanding the mechanism can help make sense of what you experience day to day on these medicines.

Appetite regulation and reduced food noise

One of the most commonly reported effects is a significant reduction in appetite — sometimes described by people taking these medicines as a quietening of "food noise", the persistent mental preoccupation with eating. This happens because GLP-1 receptors are present in areas of the brain involved in hunger signalling, and activating them promotes a sustained feeling of fullness.

Slower gastric emptying

GLP-1 receptor agonists also slow the rate at which the stomach empties after a meal. This contributes to prolonged satiety but is also the mechanism behind some of the commonly reported gastrointestinal side effects, such as nausea, particularly early in treatment or after a dose increase. This effect often lessens over time as the body adjusts.

Tirzepatide: a dual-action variant

Mounjaro (tirzepatide) acts on both GLP-1 receptors and GIP (glucose-dependent insulinotropic polypeptide) receptors, making it a dual receptor agonist. You can read more about the distinction on our page covering the GLP-1 receptor and on our overview of GLP-1 agonists as a broader group.

Once-weekly injections

Most GLP-1 receptor agonists used for weight management are administered as once-weekly subcutaneous injections using a pre-filled pen device. The dose is typically started at a low level and adjusted over time — always under the guidance of a prescriber — to balance effectiveness with tolerability. For a closer look at one medicine in this class, see our Mounjaro overview.

According to NHS guidance, these medicines are prescription-only and are not suitable for everyone; suitability is assessed individually by a qualified prescriber.

Understanding the mechanism of GLP-1 receptor agonists is one thing; living the experience week to week is another. GLP Trackr is a companion app built specifically for people already prescribed Mounjaro or Wegovy, designed to help you track every part of your journey in one place.

Because side effects like nausea or fatigue are closely tied to dose stage and timing, the side-effect tracker is one of the most useful tools on offer. Log how you feel after each dose, spot patterns over time, and build a clear picture you can bring to your next prescriber appointment — far more useful than trying to recall weeks of symptoms from memory. The GLP-1 receptor agonist tracking guide has more on making the most of this feature.

Alongside side-effect logging, the app's dose and injection logging means you always have a reliable record of when you injected, which site you used, and which dose strength — removing the guesswork that can creep in over a weekly schedule.

Always follow the guidance of your prescriber or doctor when it comes to your dose and treatment plan — GLP Trackr records and supports your journey, but it is not a substitute for their advice. If you experience symptoms that are severe, persistent, or worrying, contact your healthcare professional promptly. Any side effects worth reporting should be raised with your prescriber and, where relevant, through your national reporting scheme (such as the UK's Yellow Card scheme).

Ready to bring some structure to your weekly routine? Download GLP Trackr on the App Store or Google Play and explore everything it offers — your first 7 days are completely free.